Clinical Study | Seegene

Clinical Studies

About Seegene Clinical Studies

Seegene actively collaborates with investigators and institutions to conduct and support a wide range of clinical studies, including both Investigator-Initiated Studies (IIS) and Sponsor-Initiated Studies (SIS).

Seegene may provide a range of support—such as assays, consumables, funding, and scientific expertise—while investigators or sponsors retain responsibility for the study design, conduct, and reporting. This includes protocol development, ethical and regulatory submissions, study conduct, site and vendor management, record keeping, and data analysis for interim or final reports.

Investigators interested in collaboration are encouraged to discuss their study concepts with a designated Seegene representative during the study planning phase. Study protocols and draft publications are reviewed by Seegene prior to external submission to support scientific alignment and compliance with applicable regulatory and quality standards.

Seegene specializes in molecular diagnostics, developing multiplex PCR assays across a broad range of disease areas :
- Infectious diseases
- Women's Health
- Antimicrobial resistance (AMR)
We are particularly interested in research that explores :
- Validation of assay performance in diverse real-world clinical settings
- Population-based prevalence studies of infectious and genetic diseases
- Health economic analyses evaluating cost-effectiveness and healthcare resource utilization
- Clinical outcome studies assessing the impact of diagnostics on patient management
- Development and optimization of diagnostic algorithms

STEP 1 : Preliminary Study Proposal Submission
Please complete the online submission form with the required information, including principal investigator details, a brief study overview, and the type of support requested. As part of the submission process, a full study protocol and curriculum vitae (CV) should be submitted via email to studyproposal@seegene.com.
STEP 2 : Scientific and Feasibility Review
Submitted proposals will be reviewed by Seegene’s Clinical Study Manager to assess strategic alignment, clinical relevance, scientific validity, and overall feasibility.
STEP 3 : Decision and Next Steps
Following completion of the review, Seegene will notify the submitter of the decision via email. For approved proposals, the contract process will be initiated, and any subsequent steps will be communicated as needed.

Cancel Submit a Study